Latest news
Keep up with the latest updates
New publication - Hyperplex PCR enables highly multiplexed analysis of point mutations in wastewater
23 jan. 2025
Publications
This study highlights hpPCR’s role in swift SARS-CoV-2 variant tracking in Swedish wastewater.
Aplex Bio at the Festival of Genomics & Biodata 2025
22 jan. 2025
News
Revealing the latest advancements in Hyperplex PCR™ technology and a new era in genomic innovation.
Aplex Bio featured start-up at World Agri-Tech Innovation Summit
2 okt. 2024
News
Hyperplex PCR showcased at World Agri-Tech Innovation Summit 2024 as a groundbreaking solution for next-gen crop development and management.
hpPCR enables rapid SARS-CoV-2 variant monitoring in Swedish wastewater
30 sep. 2024
Publications
This study highlights hpPCR’s role in swift SARS-CoV-2 variant tracking in Swedish wastewater, presented by SEEC at Epizone 2024.
Hyperplex PCR to be presented at ISFG 2024
3 sep. 2024
News
Novel mRNA-Based Cell Type Identification Method to Be Showcased in Forensic Science
Aplex Bio appoints Rolf Ehrnström to Board of Directors
1 aug. 2024
News
Aplex Bio is pleased to welcome biotech veteran Rolf Ehrnström to its Board, bolstering leadership as the company advances in the molecular testing market.
Aplex Bio participates at GLOWACON
25 mars 2024
News
GLOWACON launched by the European Commission in Brussels last week.
Meet Aplex Bio at CES2024
11 dec. 2023
News
Approximately 100 Swedish companies will visit CES, covering the tech and innovation space.
Aplex Bio receives SEK 240,000 funding from Vinnova
2 nov. 2023
News
Aplex Bio receives funding from the Innovative Impact Startups autumn 2023 program
Aplex Bio recognized as top Swedish innovation on the IVA-100 list for 2023
10 maj 2023
News
The IVA-100 list is a yearly list that recognizes top research in Sweden with high scientific value and commercial potential.
